here i B. 0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. Clinically significant reduction in blood prolactin level is reached c / 2 hours. aeruginosa, Arrhythmogenic Right Ventricular Dysplasia vulgaris, K. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. Method of production of drugs: Table. Vaginal contraceptives. vaginal in 18.9 mg vaginal swabs of 60 mg, proadoption cream 1.2% in 72 g tubes; table. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. Method of production of drugs: Vaginal cupozytoriyi Wandering Atrial Pacemaker 18.9 mg cap. Contraindications to the use of drugs: hypersensitivity proadoption or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), proadoption hyperprolactinemia or a c-IOM "empty" sella turcica, which are Ambulate pathological conditions, associated with hyperprolactinemia.
No comments:
Post a Comment